FDA OKs Prucalopride (Motegrity) for Chronic Idiopathic Constipation FDA OKs Prucalopride (Motegrity) for Chronic Idiopathic Constipation

Prucalopride, a selective serotonin-4 (5-HT4) receptor agonist, enhances bowel motility by stimulating colonic peristalsis.FDA Approvals
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Gastroenterology News Alert Source Type: news